Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin.
Hajer AbdelkafiAurélien MichauValérie PonsFlora NgadjeuaAlexandra ClergetLilia Ait OuarabDavid-Alexandre BuissonDavid MontoirLucie CaramelleDaniel GilletJulien BarbierJean-Christophe CintratPublished in: Journal of medicinal chemistry (2020)
High-throughput screening has shown that Retro-1 inhibits ricin and Shiga toxins by diminishing their intracellular trafficking via the retrograde route, from early endosomes to the Golgi apparatus. To improve the activity of Retro-1, a structure-activity relationship (SAR) study was undertaken and yielded an analogue with a roughly 70-fold better half-maximal effective concentration (EC50) against Shiga toxin cytotoxicity measured in a cell protein synthesis assay.